Free Trial
LON:NFX

Nuformix (NFX) Share Price, News & Analysis

Nuformix logo
GBX 0.08 0.00 (0.00%)
As of 11:39 AM Eastern

About Nuformix Stock (LON:NFX)

Key Stats

Today's Range
0.08
0.09
50-Day Range
0.08
0.16
52-Week Range
0.04
0.30
Volume
9.43 million shs
Average Volume
55.54 million shs
Market Capitalization
£1.03 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
GBX 293
Consensus Rating
Buy

Company Overview

Nuformix Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
40th Percentile Overall Score

NFX MarketRank™: 

Nuformix scored higher than 40% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Nuformix has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Nuformix has received no research coverage in the past 90 days.

  • Read more about Nuformix's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Nuformix is -2.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Nuformix is -2.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Nuformix has a P/B Ratio of 0.16. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for NFX.
  • Dividend Yield

    Nuformix does not currently pay a dividend.

  • Dividend Growth

    Nuformix does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for NFX.
  • News Sentiment

    Nuformix has a news sentiment score of 1.11. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.96 average news sentiment score of Medical companies.
  • Search Interest

    Only 2 people have searched for NFX on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Nuformix insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    12.44% of the stock of Nuformix is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 0.12% of the stock of Nuformix is held by institutions.

  • Read more about Nuformix's insider trading history.
Receive NFX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nuformix and its competitors with MarketBeat's FREE daily newsletter.

NFX Stock News Headlines

I warned you about Nvidia… now look what’s happening
Nvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before the open. That’s the kind of move Tim Sykes built his XGPT system to trade. It scans AI news in real time, filters the noise, and pinpoints when to strike. He’s now showing exactly how it works — before the next headline hits.
See More Headlines

NFX Stock Analysis - Frequently Asked Questions

Nuformix's stock was trading at GBX 0.05 on January 1st, 2025. Since then, NFX shares have increased by 86.7% and is now trading at GBX 0.08.

Nuformix plc (LON:NFX) released its quarterly earnings data on Friday, May, 2nd. The company reported $0.03 earnings per share (EPS) for the quarter.

Shares of NFX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Nuformix investors own include Allena Pharmaceuticals (ALNA), Rolls-Royce Holdings plc (RR), UK Oil & Gas (UKOG), 88 Energy (88E), Ampliphi Biosciences (APHB), Argo Blockchain (ARB) and Ardelyx (ARDX).

Company Calendar

Last Earnings
5/02/2025
Today
7/18/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
LON:NFX
Previous Symbol
LON:LVRT
CIK
N/A
Fax
N/A
Employees
3
Year Founded
N/A

Price Target and Rating

High Price Target
GBX 293
Low Price Target
GBX 293
Potential Upside/Downside
+348,709.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
GBX (0.03)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£383.40 thousand
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-5.68%
Return on Assets
-17.20%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.12
Quick Ratio
3.35

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
GBX 0.02 per share
Price / Cash Flow
3.55
Book Value
GBX 0.54 per share
Price / Book
0.16

Miscellaneous

Outstanding Shares
1,231,809,091
Free Float
N/A
Market Cap
£1.03 million
Optionable
Not Optionable
Beta
1.22
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (LON:NFX) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners